Publications by authors named "Ebrahim Ranjbar"
Introduction: HIV drug resistance (HIVDR) is an important challenge in the fight against HIV/AIDS and can threaten progress toward achieving the target of HIV elimination by 2030. Genotyping pretreatment HIVDR testing (DRT) has been proposed as a potential solution. However, the cost-effectiveness of this intervention needs to be evaluated to determine its feasibility and potential impact on healthcare systems.
View Article and Find Full Text PDFArticle Synopsis
- Hepatitis E virus (HEV) infection is more prevalent among HIV-1 patients and can lead to severe liver issues like chronic infection and cirrhosis.
- A study compared 87 HIV-1-positive individuals to 93 healthy controls in Iran, checking for HEV through serological tests and RNA detection methods.
- Results showed a significantly higher presence of HEV RNA in HIV-1 patients (8%) compared to non-HIV individuals (1.1%), indicating the need for routine HEV testing in those with HIV-1 and liver problems.
Article Synopsis
- * Facilitators include aspects like trust in the health system, support from family, and the positive impact of societal attitudes, while barriers encompass issues like financial constraints, stigma, and logistical challenges.
- * The findings suggest that improving management of these factors by healthcare providers could enhance service access and encourage more PLWH to utilize available HIV prevention, treatment, and care services.
Article Synopsis
- - The study examined the trends and geographic spread of HIV diagnoses in Kerman, Iran, from 1997 to 2020, analyzing various factors like age, gender, and transmission methods in three distinct time periods.
- - A total of 459 individuals were diagnosed, with a notable increase in the proportion of women and sexual transmission cases over time, highlighting demographic shifts in the HIV epidemic.
- - The findings suggested that while certain aspects of HIV diagnoses improved, such as a rise in pediatric cases, the overall health of diagnosed individuals (as measured by CD4 counts) did not show significant progress, indicating the need for targeted prevention and treatment strategies.